Selection and stability for a recombinant CHO cell line expressing human GM-CSF in gene amplification

被引:0
|
作者
Omasa, T [1 ]
Itami, S [1 ]
Kameoka, D [1 ]
Katakura, Y [1 ]
Suga, K [1 ]
机构
[1] Osaka Univ, Grad Sch Engn, Biochem Engn Lab, Dept Biotechnol, Suita, Osaka 565, Japan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the relationship between the specific production rate and the concentration of the toxic drug methotrexate (MTX), inhibitory to nucleic acid synthesis in the medium, during the construction of recombinant CHO cells. The results of selection of MTX tolerant cells when the MTX concentration was increased under 10 different stepwise conditions showed that the number of days required to obtain cells resistant to 1000 nM MTX depended on the selection conditions. Tolerant cells were obtained most rapidly at an MTX concentration of 10nM. With increasing MTX concentration, the specific production rate increased, while the specific growth rate gradually decreased. In the case of a gradual increase in the MTX concentration, the specific production rate reached a higher level. We also investigated the stability of the specific production rate during cultivation over a long period with or without MTX. In long-term cultivation, the specific production rate decreased, while the specific growth rate remained at the same level. The specific production rate in a culture without MTX decreased more rapidly than that in a culture with MTX.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [1] Recombinant vaccinia virus expressing GM-CSF for cancer gene therapy.
    Brown, DJ
    Chatterjjee, SK
    Miller, CS
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 861 - 861
  • [2] IMMUNOAFFINITY PURIFICATION OF RECOMBINANT HUMAN GM-CSF
    SHARMA, B
    ABRAMS, J
    TROTTA, PP
    NAGABHUSHAN, TL
    SEELIG, GF
    FASEB JOURNAL, 1988, 2 (05): : A1010 - A1010
  • [3] MODULATION OF FUNCTIONS OF GRANULOCYTES BY RECOMBINANT HUMAN GM-CSF AND POSSIBLE COMPLICATIONS OF GM-CSF THERAPY
    KLAUSMANN, M
    PFLUGER, KH
    KRUMWIEH, D
    SEILER, FR
    HAVEMANN, K
    LEUKEMIA, 1988, 2 (12) : S63 - S72
  • [4] Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine
    Chatterjee, SK
    Qin, HX
    Manna, S
    Tripathi, PK
    ANTICANCER RESEARCH, 1999, 19 (4B) : 2869 - 2873
  • [5] ACTION OF RECOMBINANT HUMAN GM-CSF ON GRANULOCYTE FUNCTIONS
    KLAUSMANN, M
    HADER, M
    PFLUGER, KH
    KRUMWIEH, D
    HAVEMANN, K
    BLUT, 1987, 55 (04): : 218 - 218
  • [6] RECOMBINANT HUMAN GM-CSF IN MYELOSUPPRESSION OF CHEMOTHERAPY (CONTINUED)
    BAR, MH
    ARONSON, FR
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14): : 939 - 940
  • [7] Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF
    Qin, HX
    Chatterjee, SK
    HUMAN GENE THERAPY, 1996, 7 (15) : 1853 - 1860
  • [8] ACTIVITY OF RECOMBINANT HUMAN G-CSF AND GM-CSF ON CFU-GM SUBPOPULATIONS
    FERRERO, D
    TARELLA, C
    BADONI, R
    BELLONE, G
    CARACCIOLO, D
    GALLO, E
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 554 - 554
  • [9] Construction and in vitro evaluation of a recombinant live attenuated PRRSV expressing GM-CSF
    Lingxue Yu
    Yanjun Zhou
    Yifeng Jiang
    Wu Tong
    Shen Yang
    Fei Gao
    Kang Wang
    Liwei Li
    Tianqi Xia
    Qun Cheng
    Guangzhi Tong
    Virology Journal, 11
  • [10] Generation and utilization of a HEK-293T murine GM-CSF expressing cell line
    Robinson, Elektra Kantzari
    Covarrubias, Sergio
    Zhou, Simon
    Carpenter, Susan
    PLOS ONE, 2021, 16 (04):